Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-021651
Filing Date
2014-05-29
Accepted
2014-05-29 16:56:53
Documents
1
Period of Report
2014-05-28

Document Format Files

Seq Description Document Type Size
1 rrd409457.html 4  
1 rrd409457.xml 4 3770
  Complete submission text file 0001181431-14-021651.txt   5082
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11 ACORN LANE LOS ALTOS CA 94022
Business Address
CANO FRANCIS (Reporting) CIK: 0001286710 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 14876754